EKRA COMPLEMENTARY MEDICINE LIMITED
Summary
EKRA COMPLEMENTARY MEDICINE LIMITED was set up on Wednesday, October 5, 2011. Their current partial address is 155 CHURCH ROAD and the company status is Active - Proposal to Strike off.
Credit Score
Latest Accounts Filed:
31/10/2020
Next Set of Accounts Due:
31/07/2022
Company Vitals
Company Name:
EKRA COMPLEMENTARY MEDICINE LIMITED
Time in Business:
13 years
Company Number:
07797612
Current Status:
Active - Proposal to Strike off
Company Category:
Private Limited Company
Country of Origin:
United Kingdom
Principal Activity:
[74909] - Other professional, scientific and technical activities n.e.c.
Registered Address:
155 CHURCH ROAD
YARDLEY
BIRMINGHAM
ENGLAND
B25 8UP
Filing History
Submission | Date | Type |
---|---|---|
Dissolved compulsory strike off suspended | 2022-08-09 | DISS16(SOAS) |
Gazette notice compulsory | 2022-07-05 | GAZ1 |
Termination director company with name termination date | 2022-04-04 | TM01 |
Cessation of a person with significant control | 2022-04-04 | PSC07 |
Termination secretary company with name termination date | 2022-04-04 | TM02 |
Change registered office address company with date old address new address | 2022-04-04 | AD01 |
Confirmation statement with no updates | 2021-12-07 | CS01 |
Accounts with accounts type micro entity | 2021-07-30 | AA |
Confirmation statement with no updates | 2020-10-21 | CS01 |
Accounts with accounts type micro entity | 2020-10-09 | AA |
Gazette filings brought up to date | 2020-01-11 | DISS40 |
Change registered office address company with date old address new address | 2020-01-08 | AD01 |
Confirmation statement with no updates | 2020-01-08 | CS01 |
Gazette notice compulsory | 2020-01-07 | GAZ1 |
Accounts with accounts type micro entity | 2019-07-29 | AA |
Confirmation statement with no updates | 2018-10-26 | CS01 |
Accounts with accounts type micro entity | 2018-07-27 | AA |
Confirmation statement with no updates | 2017-10-16 | CS01 |
Accounts with accounts type total exemption small | 2017-02-17 | AA |
Confirmation statement with updates | 2016-10-10 | CS01 |